Bent Frandsen

Amministratore Delegato presso EXPRES2ION BIOTECH HOLDING AB

Health Technology

Consumer Services

Profilo

Bent U.
Frandsen currently works at ExpreS2ion Biotechnologies ApS, as Chief Executive Officer and Expres2ion Biotech Holding AB, as Chief Executive Officer from 2019.
Mr. Frandsen also formerly worked at Adaptvac ApS, as Director and NsGene A, as Vice President-Business Development.
Mr. Frandsen received his graduate degree in 1993 from Copenhagen Business School.

Posizioni attive di Bent Frandsen

Società	Posizione	Inizio
EXPRES2ION BIOTECH HOLDING AB	Amministratore Delegato	20/12/2019
ExpreS2ion Biotechnologies ApS ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology Operates as a biotech company which engages in the field of protein production in Drosophila Schneider-2 cells	Amministratore Delegato	-

Tutte le posizioni attive di Bent Frandsen

Precedenti posizioni note di Bent Frandsen

Società	Posizione	Fine
NsGene A/S NsGene A/S Pharmaceuticals: MajorHealth Technology Provides therapeutic products for the treatment of neurodegenerative disorders	Corporate Officer/Principal	-
Adaptvac ApS Adaptvac ApS BiotechnologyHealth Technology Develops therapeutic and prophylactic vaccines	Direttore/Membro del Consiglio	-

Vedi nel dettaglio l'esperienza di Bent Frandsen

Formazione di Bent Frandsen

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Vedi nel dettaglio l'esperienza di Bent Frandsen

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	5
Copenhagen Business School Copenhagen Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
NsGene A/S NsGene A/S Pharmaceuticals: MajorHealth Technology Provides therapeutic products for the treatment of neurodegenerative disorders	Health Technology
ExpreS2ion Biotechnologies ApS ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology Operates as a biotech company which engages in the field of protein production in Drosophila Schneider-2 cells	Health Technology
Expres2ion Biotech Holding AB Expres2ion Biotech Holding AB BiotechnologyHealth Technology Engages in the development of a portfolio of vaccines for diseases such as COVID-19, influenza, and breast cancer	Health Technology
Adaptvac ApS Adaptvac ApS BiotechnologyHealth Technology Develops therapeutic and prophylactic vaccines	Health Technology